- Home
- QDEL vs XPEL Comparison
QDEL vs XPEL Comparison
Compare QDEL & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QDEL | XPEL |
|---|---|---|
| Founded | 1979 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | QDEL | XPEL |
|---|---|---|
| Price | $19.94 | $39.94 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $32.75 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 249.5K |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.35 | 12.12 |
| EPS | N/A | ★ 1.85 |
| Revenue | ★ $2,730,200,000.00 | $476,200,000.00 |
| Revenue This Year | $3.51 | $12.64 |
| Revenue Next Year | $3.86 | $11.98 |
| P/E Ratio | ★ N/A | $21.79 |
| Revenue Growth | N/A | ★ 13.27 |
| 52 Week Low | $19.50 | $24.27 |
| 52 Week High | $38.46 | $55.91 |
Technical Indicators
Market Signals| Indicator | QDEL | XPEL |
|---|---|---|
| Relative Strength Index (RSI) | 29.71 | 25.20 |
| Support Level | $19.50 | $35.10 |
| Resistance Level | $30.65 | $55.36 |
| Average True Range (ATR) | 1.28 | 2.31 |
| MACD | -0.10 | -0.90 |
| Stochastic Oscillator | 15.25 | 10.45 |
Price Performance
Historical ComparisonAbout QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.